{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:02:08Z","timestamp":1746417728811,"version":"3.40.4"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","license":[{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Dong Guo","award":["No. XSLP-2013-35"],"award-info":[{"award-number":["No. XSLP-2013-35"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>: As a compound preparation of traditional Chinese and western medicine included in Volume 20 of Chinese traditional Medicine prescription, Zhenju antihypertensive tablet has been widely used in the treatment of patients with essential hypertension (EH) for many years. This study intends to evaluate the efficacy, safety and vascular endothelial function of Zhenju antihypertensive tablet in the treatment of essential hypertension.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>: The search strategies of different websites were searched on Cochrane Central controlled Trials Registry, PubMed, excerpt database, Chinese Biomedical Literature Database, China National knowledge Infrastructure, Chinese Science and Technology Journal Database, WanFang, and other websites. All qualified studies were confirmed to include randomized controlled trials. The search time range was from January 1, 1900 to August 31, 2021. At the same time, the list of references and related reviews were checked. Two evaluators were responsible for the extraction and management of the data independently. The literature quality was evaluated according to Cochrane manual 4.2.2. Heterogeneity test and Meta analysis were carried out by Review ManagerV.5.3 software. The bias risk included in the study was evaluated by Cochrane \u201cbias risk\u201d tool. In addition, the relevant statistical data were evaluated by GRADE3.6 evidence quality grading system.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>: This study intends evaluate the efficacy and safety of Zhenju antihypertensive tablet in the treatment of EH from 4 aspects, including changes in blood pressure (systolic blood pressure, diastolic Blood pressure), effective hypotension, changes in endothelial function (NO, the level of plasma endothelin-1 in serum), and adverse reactions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>: The conclusion of this study intends to provide evidence for judging the effectiveness and safety of ZJAHC intervention on EH patients and their endothelial function.<\/jats:p>\n            <jats:p>PROSPERO registration number: PROSPERO CRD42021235309.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000027501","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T17:00:29Z","timestamp":1637341229000},"page":"e27501","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of the effects of Zhenju antihypertensive tablet on efficacy, safety and vascular endothelial function in patients with essential hypertension"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9607-4386","authenticated-orcid":false,"given":"Jisen","family":"Zhao","sequence":"first","affiliation":[{"name":"The First Clinical Medical College of Shandong University of Traditional Chinese Medicine, Jinan City, Shandong Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Guo","sequence":"additional","affiliation":[{"name":"Teacher Development Center of Shandong University of Traditional Chinese Medicine, Jinan City, Shandong Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maoxia","family":"Fan","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College of Shandong University of Traditional Chinese Medicine, Jinan City, Shandong Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongcheng","family":"Liu","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College of Shandong University of Traditional Chinese Medicine, Jinan City, Shandong Province, China"},{"name":"Shandong Provincial Hospital of Traditional Chinese Medicine, Jinan, Shandong Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,11,19]]},"reference":[{"key":"R1-20250504","first-page":"01","article-title":"Summary of China cardiovascular disease report 2017","volume":"33","author":"Chen","year":"2018","journal-title":"Chin Circulation J"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.290.2.199","article-title":"Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000","volume":"290","author":"Hajjar","year":"2003","journal-title":"JAMA"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/S0140-6736(18)32225-6","article-title":"Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.aogh.2016.02.002","article-title":"Hypertension and related cardiovascular disease burden in China","volume":"82","author":"Bundy","year":"2016","journal-title":"Ann Glob Health"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"3104945","DOI":"10.1155\/2018\/3104945","article-title":"Association of impaired vascular endothelial function with increased cardiovascular risk in asymptomatic adults","volume":"2018","author":"Zhong","year":"2018","journal-title":"Biomed Res Int"},{"key":"R6-20250504","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvaa085","article-title":"Endothelial function in cardiovascular medicine: a consensus paper of the European Society of Cardiology Working Groups on Atherosclerosis and Vascular Biology, Aorta and Peripheral Vascular Diseases, Coronary Pathophysiology and Microcirculation, and Thrombosis","volume":"117","author":"Alexander","year":"2021","journal-title":"Cardiovasc Res"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0008-6363(01)00473-4","article-title":"Endothelial function, vascular reactivity and gender differences in the cardiovascular system","volume":"53","author":"Sader","year":"2002","journal-title":"Cardiovasc Res"},{"key":"R8-20250504","first-page":"883","article-title":"Detection of vascular endothelial function","volume":"24","author":"Xiao","year":"2016","journal-title":"Chin J Hypertension"},{"key":"R9-20250504","first-page":"1121","article-title":"Preliminary study on related substances of Zhenju Jiangya tablets","volume":"40","author":"Guo","year":"2020","journal-title":"Chin J Pharmaceutical Analysis"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/jphp.12207","article-title":"Enhanced absorption and bioavailability of hydrochlorothiazide by Chinese medicines in the Zhenju antihypertensive compound","volume":"66","author":"Qin","year":"2014","journal-title":"J Pharm Pharmacol"},{"key":"R11-20250504","first-page":"1289","article-title":"Effect of Zhenju antihypertensive tablet on mild to moderate hypertension","volume":"8","author":"Shi","year":"2010","journal-title":"Chin J Integrative Med Cardio-Cerebrovascular Dis"},{"key":"R12-20250504","first-page":"801","article-title":"Efficacy of Zhenju antihypertensive tablet in the treatment of 80 cases of primary hypertension","volume":"30","author":"Lin","year":"2008","journal-title":"Chin Traditi Patent Med"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/bmc.3393","article-title":"Development of an LC-MS\/MS method for determining the pharmacokinetics of clonidine following oral administration of Zhenju antihypertensive compound","volume":"29","author":"Qin","year":"2015","journal-title":"Biomed Chromatogr"},{"key":"R14-20250504","first-page":"08","article-title":"GRADE: grade of evidence quality and strength of recommendation consensus","volume":"9","author":"Gordon H","year":"2009","journal-title":"Chin J Evidence-Based Med"},{"key":"R15-20250504","first-page":"1036","article-title":"Literature analysis on adverse reactions of four kinds of Chinese and Western medicine compound preparations","volume":"23","author":"Yang","year":"2012","journal-title":"China Pharmacy"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:06:45Z","timestamp":1746335205000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027501"}},"subtitle":["A protocol for systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,11,19]]},"references-count":15,"journal-issue":{"issue":"46","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000027501","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,11,19]]},"assertion":[{"value":"2021-09-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}